Clinical Trial Update: PoC in Rheumatoid Arthritis With Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial in rheumatoid arthritis evaluating a Bristol-Myers Squibb investigational agent in combination with methotrexate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis, NOS | Phase 2 | Status: COMPLETED